,name,moa,targets,status,GBM_CT,NCS,WTCS_Pval,Tau,FDA_database
1,SC-144,P glycoprotein inhibitor,,Preclinical,FALSE,-1.65160389,2.34E-05,-99.44556055,NA
2,API-001,sigma receptor antagonist,SIGMAR1,Phase 2,FALSE,-1.513269887,2.51E-05,-97.66899078,NA
3,CP-339818,potassium channel blocker,KCNA3,Preclinical,FALSE,-1.482797823,2.55E-05,-97.10962735,NA
4,stemregenin-1,aryl hydrocarbon receptor antagonist,AHR,Preclinical,FALSE,-1.449682905,2.59E-05,-95.35472308,NA
5,CGM-097,selective inhibitor of p53-Mdm2 interaction,NA,NA,FALSE,-1.438155716,2.60E-05,-97.47301662,NA
6,AZD-5363/capivasertib,selective ATP-competitive pan-AKT kinase inhibitor,NA,NA,FALSE,-1.43617082,2.60E-05,-96.17308753,NA
7,entinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC9",Phase 3,FALSE,-1.434199841,2.61E-05,-96.99145198,NA
8,GS-9973,SYK inhibitor,SYK,Phase 2,FALSE,-1.421132605,2.62E-05,-96.50397857,NA
9,Ro-20-1724,phosphodiesterase inhibitor,"PDE3A, PDE4A, PDE4B, PDE4C, PDE4D",Preclinical,FALSE,-1.380085389,2.67E-05,-96.33262428,NA
10,N20C,glutamate receptor antagonist,,Preclinical,FALSE,-1.365275731,2.69E-05,-95.9140865,NA
11,LY-456236,Selective mGlu1 antagonist,NA,NA,FALSE,-1.361178857,2.69E-05,-97.01114788,NA
12,SKI-II,sphingosine kinase inhibitor,SPHK1,Preclinical,FALSE,-1.346579757,2.71E-05,-94.20842196,NA
13,taselisib,PI3K inhibitor,PIK3CA,Phase 3,FALSE,-1.320280181,2.75E-05,-91.8478689,NA
14,fludarabine,ribonucleotide reductase inhibitor,"ADA, DCK, POLA1, RRM1, RRM2",Launched,TRUE,-1.318214923,2.75E-05,-92.47321358,Prescription/Discontinued
15,SM-21,sigma receptor antagonist,PGRMC1,Preclinical,FALSE,-1.305579277,2.76E-05,-93.74655322,NA
16,rucaparib,PARP inhibitor,"PARP1, PARP2",Phase 3,TRUE,-1.295509599,2.78E-05,-95.6137241,Prescription
17,diflunisal,prostanoid receptor antagonist,"PTGS1, PTGS2",Launched,FALSE,-1.287010274,2.79E-05,-93.12022375,Prescription/Discontinued
18,tiagabine,GABA uptake inhibitor,SLC6A1,Launched,FALSE,-1.279804054,2.80E-05,-92.16201844,Prescription/Discontinued
19,thioridazine,dopamine receptor antagonist,"DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7",Withdrawn,FALSE,-1.268857438,2.83E-05,-91.23631135,Prescription/Discontinued
20,flupirtine,glutamate receptor antagonist,"ADRA2A, KCNQ1, KCNQ2",Launched,FALSE,-1.255926741,2.89E-05,-89.71381864,NA
21,papaverine,phosphodiesterase inhibitor,"PDE10A, PDE4B, PDE5A",Launched,FALSE,-1.254456204,2.89E-05,-83.86019853,NA
22,BI-2536,PLK inhibitor,"BRD4, PLK1, PLK2, PLK3",Phase 2,FALSE,-1.248349267,2.94E-05,-91.42342236,NA
23,AZ-628,RAF inhibitor,"BRAF, RAF1",Preclinical,FALSE,-1.246160508,2.97E-05,-87.56992043,NA
24,vemurafenib,RAF inhibitor,"BRAF, RAF1",Launched,FALSE,-1.241647514,2.99E-05,-91.31509493,Prescription
25,vorinostat,HDAC inhibitor,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC5, HDAC6, HDAC8, HDAC9",Launched,TRUE,-1.232894963,3.04E-05,-94.44280312,Prescription
26,piceatannol,SYK inhibitor,"ATP5A1, ATP5B, ATP5C1, IRF3",Preclinical,FALSE,-1.230022358,3.07E-05,-90.04963366,NA
27,PI-103,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC",Preclinical,FALSE,-1.220856523,3.25E-05,-80.14949185,NA
28,suprofen,cyclooxygenase inhibitor,"PTGS1, PTGS2",Withdrawn,FALSE,-1.211343839,3.44E-05,-89.23619318,Discontinued
29,NNC-05-2090,"GABA uptake inhibitor, GAT inhibitor",SLC6A12,Preclinical,FALSE,-1.210983032,3.44E-05,-86.59891279,NA
30,dasatinib,"Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, SRC inhibitor, tyrosine kinase inhibitor","ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1",Launched,TRUE,-1.207150246,3.52E-05,-90.23969905,Prescription/Discontinued
31,saxagliptin,dipeptidyl peptidase inhibitor,DPP4,Launched,FALSE,-1.204065808,3.62E-05,-80.36220752,Prescription/Discontinued/None (TENTATIVE APPROVAL)
32,LY-294002,Specific inhibitor of phosphatidylinositol 3-kinase.,"PIM1, PIK3CG",NA,FALSE,-1.202316434,3.79E-05,-87.96186875,NA
33,rimonabant,cannabinoid receptor antagonist,"CNR1, GPR55",Withdrawn,FALSE,-1.200733711,3.79E-05,-85.73820216,NA
34,panobinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7, HDAC8, HDAC9",Launched,TRUE,-1.200116761,3.79E-05,-89.04120381,Discontinued
35,nifedipine,calcium channel blocker,"CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNB2, CALM1, GLRA1, GLRA3, GLRB, KCNA1, KCNA5, NR1I2, TRPM3",Launched,FALSE,-1.199300818,3.91E-05,-86.46891988,Prescription/Discontinued
36,ranirestat,aldose reductase inhibitor,AKR1B1,Phase 3,FALSE,-1.190961386,4.20E-05,-86.08091074,NA
37,VS-4718,focal adhesion kinase inhibitor,,Phase 1,FALSE,-1.187208411,4.38E-05,-85.3354211,NA
38,GDC-0349,Pim kinase inhibitor,PIK3CA,Phase 1,FALSE,-1.186689325,4.38E-05,-85.65941858,NA
39,PF-02545920,phosphodiesterase inhibitor,PDE10A,Phase 2,FALSE,-1.173876424,5.31E-05,-84.3555503,NA
40,anguidine,protein synthesis inhibitor,SLC5A1,Phase 2,FALSE,-1.172328848,5.31E-05,-82.56223903,NA
41,SAL-003,elf-2a phosphatase inhibitor,NA,NA,FALSE,-1.15789051,6.71E-05,-83.85035059,NA
42,camostat-mesilate,protease inhibitor,PRSS1,Launched,FALSE,-1.157333361,6.71E-05,-82.94926337,NA
43,harmane,monoamine oxidase inhibitor,"MAOA, MAOB",Preclinical,FALSE,-1.157243872,6.71E-05,-86.031671,NA
44,KU-0063794,mTOR inhibitor,MTOR,Preclinical,FALSE,-1.156976534,6.71E-05,-86.28968723,NA
45,spironolactone,mineralocorticoid receptor antagonist,"AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, NR3C1, NR3C2, PGR, SHBG",Launched,FALSE,-1.151373868,7.74E-05,-82.33081226,Prescription/Discontinued
47,obatoclax,BCL inhibitor,BCL2,Phase 3,FALSE,-1.143526634,8.92E-05,-81.64637989,NA
48,L-693403,"sigma receptor agonist, sigma receptor antagonist","DRD2, SIGMAR1",Preclinical,FALSE,-1.136634138,0.000103269,-81.18254156,NA
50,SGX-523,A MET receptor tryosine Kinase inhibitor,MET,NA,FALSE,-1.134550605,0.000111842,-84.9779406,NA
51,ambenonium,cholinesterase inhibitor,ACHE,Launched,FALSE,-1.132297342,0.000111842,-81.93295517,Discontinued
52,lapatinib,EGFR inhibitor,"EGFR, ERBB2",Launched,TRUE,-1.128590777,0.000121808,-82.97979201,Prescription
53,maltobionic-acid,matrix metalloprotease inhibitor,,Launched,FALSE,-1.128078866,0.000131709,-82.4539116,NA
54,pentoxifylline,phosphodiesterase inhibitor,"ADORA1, ADORA2A, ADORA2B, ADRA2B, NT5E, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, TNF",Launched,TRUE,-1.125650176,0.000131709,-80.80536516,Prescription/Discontinued
57,"BRD-K37846922/ 3,3'-diindolylmethane",NA,NA,NA,FALSE,-1.117211974,0.000167807,-80.24698653,NA
58,siramesine,sigma receptor antagonist,"ADRA1A, ADRA1B, ADRA1D",Phase 2,FALSE,-1.113518566,0.000182865,-82.4352005,NA
63,icosapent,platelet aggregation inhibitor,"ACSL3, ACSL4, FADS1, FFAR1, PPARD, PPARG, PTGS1, PTGS2, SLC8A1, TRPV1",Launched,FALSE,-1.100594436,0.000240222,-80.23910817,Prescription/Discontinued
64,DPCPX,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3",Phase 1,FALSE,-1.099382178,0.00026259,-82.44800284,NA
65,BRD-K58930050/ Dizocilpine (MK-801),"antagonist of the N-Methyl-D-aspartate receptor, a glutamate receptor",NA,NA,FALSE,-1.099218741,0.00026259,-83.13834397,NA
66,pamidronate,bone resorption inhibitor,FDPS,Launched,FALSE,-1.089024431,0.000316771,-81.30367131,Prescription/Discontinued
69,erlotinib,EGFR inhibitor,"EGFR, NR1I2",Launched,TRUE,-1.078583103,0.000416711,-82.69223194,Prescription/Discontinued
71,tetrindole,monoamine oxidase inhibitor,MAOA,Phase 3,FALSE,-1.075580309,0.000457096,-80.20660994,Na